KORU Medical Systems (NASDAQ:KRMD) Price Target Raised to $3.50 at Piper Sandler

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) had its price objective increased by research analysts at Piper Sandler from $3.00 to $3.50 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an "overweight" rating on the stock. Piper Sandler's price target indicates a potential upside of 13.64% from the stock's current price.

Separately, B. Riley initiated coverage on shares of KORU Medical Systems in a research note on Thursday, July 25th. They issued a "buy" rating and a $4.00 price target on the stock.

KORU Medical Systems Stock Down 3.8 %

NASDAQ:KRMD traded down $0.12 on Thursday, hitting $3.08. 98,985 shares of the company's stock were exchanged, compared to its average volume of 114,756. The company has a market cap of $141.23 million, a P/E ratio of -12.32 and a beta of 0.41. KORU Medical Systems has a 52 week low of $1.98 and a 52 week high of $3.40. The firm has a 50-day moving average price of $2.64 and a 200-day moving average price of $2.46. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.77 and a quick ratio of 3.27.

Institutional Investors Weigh In On KORU Medical Systems

Hedge funds have recently modified their holdings of the stock. Connor Clark & Lunn Investment Management Ltd. lifted its stake in KORU Medical Systems by 77.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company's stock worth $168,000 after purchasing an additional 26,860 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in KORU Medical Systems in the second quarter worth about $107,000. Meros Investment Management LP raised its position in shares of KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company's stock worth $2,132,000 after purchasing an additional 137,918 shares during the last quarter. Legato Capital Management LLC purchased a new stake in KORU Medical Systems during the 2nd quarter valued at $35,000. Finally, Allspring Global Investments Holdings LLC bought a new stake in shares of KORU Medical Systems in the second quarter worth approximately $28,000. Institutional investors own 58.60% of the company's stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.